Science
Science & Formulation
The science behind Mayntain
How a carefully developed GLP-1 supplement translates the latest insights from metabolic health into something you can use daily.
GLP-1 support • Metabolic health • Satiety regulation • Blood sugar balance • Scientifically substantiated
GLP-1, or glucagon-like peptide-1, is a gut hormone that has evolved from a relatively unknown physiological phenomenon into one of the most researched molecules in modern medicine. Mayntain is built on this scientific foundation.
When pharmaceutical companies began investigating the mechanisms behind GLP-1, drugs like semaglutide emerged. But a deeper question remained: can the body's natural production of this hormone be supported through nutrition and targeted supplementation? That is the question Mayntain addresses.
What is GLP-1 and why is it important?
GLP-1 is secreted by L-cells in the intestinal wall, primarily in response to food intake. It stimulates insulin release, inhibits glucagon, slows gastric emptying, and sends satiety signals to the brain. It functions as the body's natural brake on appetite and post-meal blood sugar spikes.
In individuals with obesity, insulin resistance, or type 2 diabetes, this GLP-1 response is often impaired. Less is produced, or sensitivity to the hormone decreases. As a result, the natural control over overeating and glucose imbalance becomes less effective. Mayntain focuses on supporting and strengthening these natural processes.
7-9 minutes
Average half-life of endogenous GLP-1
~30% lower
GLP-1 response often seen in obesity
2× higher
GLP-1 release after fiber-rich meals
The formulation: five ingredients, one goal
Mayntain's formula is based on ingredients whose effects on GLP-1 release, insulin sensitivity, or satiety have been studied in scientific research. No fillers and no proprietary blends that conceal dosages.
01 — Berberine HCl
Activates AMPK, increases GLP-1 release, and supports insulin sensitivity. Several meta-analyses show positive effects on fasting glucose levels and HbA1c.
02 — Psyllium Fiber
A soluble fiber that slows gastric emptying and supports the release of GLP-1 and PYY from intestinal L-cells.
03 — Curcumin + piperine
Curcumin influences inflammatory pathways that contribute to insulin resistance. Piperine significantly increases the bioavailability of curcumin.
04 — Chromium Picolinate
A trace element that supports insulin signaling and can help reduce carbohydrate cravings, especially during calorie restriction.
05 — Inulin (chicory root)
A prebiotic fiber that feeds bacterial strains associated with increased GLP-1 production via short-chain fatty acids.
06 — Akkermansia muciniphila
One of the most researched bacterial strains in metabolic health. Akkermansia muciniphila supports the intestinal barrier, microbiome, and metabolic functions linked to GLP-1 signaling and insulin sensitivity.
Research shows that lower levels of Akkermansia are often found in obesity, insulin resistance, and metabolic dysfunction. By supporting a healthy gut environment, Akkermansia can contribute to improved gut function, satiety, and overall metabolic balance.
How the gut microbiome is connected to GLP-1
One of the most striking discoveries in recent metabolic research is that gut bacteria do not play a passive role, but are actively involved in the regulation of GLP-1 production.
When certain bacterial strains ferment dietary fiber, they produce short-chain fatty acids such as butyrate, propionate, and acetate. These substances directly stimulate L-cells to release more GLP-1.
The inulin in the Mayntain formula acts as a selective prebiotic that specifically supports these bacterial strains. In doing so, Mayntain chooses a more fundamental approach: supporting the biological conditions in which healthy GLP-1 production becomes possible.
1 — Inulin feeds beneficial gut bacteria
Prebiotic fibers selectively support Lactobacillus and Bifidobacterium strains in the large intestine.
2 — Fermentation produces short-chain fatty acids
During fermentation, butyrate, propionate, and acetate are produced, which are important metabolic signaling molecules.
3 — SCFAs stimulate L-cells
Short-chain fatty acids activate receptors on intestinal L-cells, thereby stimulating GLP-1 and PYY release.
4 — Satiety and glucose signals reach the brain
Increased GLP-1 levels slow gastric emptying, reduce appetite, and support more stable blood sugar levels.
The role of inflammation
Chronic low-grade inflammation is increasingly seen as a major cause of metabolic dysfunction and impaired GLP-1 signaling.
Increased inflammatory markers such as TNF-α and IL-6 disrupt both the release of GLP-1 from L-cells and the sensitivity of receptors. This creates a vicious cycle where poor metabolic health promotes inflammation, and inflammation further worsens metabolic health.
Curcumin, present in the Mayntain formula, has been extensively studied for its influence on NF-κB, a key regulator of inflammatory processes. By helping to reduce this low-grade inflammatory burden, the formula can support conditions in which GLP-1 functions more effectively.
"The relationship between gut inflammation, microbiome composition, and incretin hormones is one of the most promising areas of research in metabolic medicine."
Research context — GLP-1 & metabolic health
What Mayntain is and isn't
Mayntain is not a GLP-1 receptor agonist. It does not inject or synthesize the hormone, nor does it mimic it pharmacologically.
What it does aim to do is support the physiological conditions in which the body more efficiently produces and uses its own GLP-1. This occurs through fiber intake, AMPK activation, microbiome support, and influencing inflammatory processes.
This distinction is important. Pharmaceutical GLP-1 medications have powerful and direct effects, but also carry potential side effects and require medical supervision. A supplement falls into a different category: more gradual, milder, and intended for people seeking metabolic support as part of a broader lifestyle approach.
The honest approach is this: the science behind the individual ingredients in the Mayntain formula is based on peer-reviewed research. The translation of that science into a specific commercial product, with certain dosages and combinations, remains something where critical evaluation is appropriate, as with any supplement.
This article is for informational purposes only and does not constitute medical advice. Mayntain supplements are not intended to diagnose, treat, cure, or prevent any disease. Always consult a doctor or medical professional before starting supplement use.